Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2012-09-13 11:42:12 UTC |
---|
Update Date | 2023-02-21 17:28:59 UTC |
---|
HMDB ID | HMDB0041842 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Bufotenin |
---|
Description | A hallucinogenic serotonin analog found in frog or toad skins, mushrooms, higher plants, and mammals, especially in the brains, plasma, and urine of schizophrenics. Bufotenin has been used as a tool in CNS studies and misused as a psychedelic. Bufotenin (5-OH-DMT), is a tryptamine related to the neurotransmitter serotonin. It is an alkaloid found in the skin of some species of toads; in mushrooms, higher plants, and mammals. Bufotenin is a chemical constituent in the venom and eggs of several species of toads belonging to the Bufo genus, but most notably in the Colorado River toad (Bufo alvarius) as it is the only toad species in which bufotenin is present in large enough quantities for a psychoactive effect. Extracts of toad venom, containing bufotenin and other bioactive compounds, have been used in some traditional medicines (probably derived from Bufo gargarizans), which has been used medicinally for centuries in China. Bufotenin is a constituent of the seeds of Anadenanthera colubrina and Anadenanthera peregrina trees. Anadenanthera seeds have been used as an ingredient in psychedelic snuff preparations by indigenous cultures of the Caribbean, Central and South America. |
---|
Structure | CN(C)CCC1=CNC2=C1C=C(O)C=C2 InChI=1S/C12H16N2O/c1-14(2)6-5-9-8-13-12-4-3-10(15)7-11(9)12/h3-4,7-8,13,15H,5-6H2,1-2H3 |
---|
Synonyms | Value | Source |
---|
3-[2-(Dimethylamino)ethyl]-5-indolol | ChEBI | 3-[2-(Dimethylamino)ethyl]indol-5-ol | ChEBI | 3-[beta-(Dimethylamino)ethyl]-5-hydroxyindole | ChEBI | 5-Hydroxy-N,N-dimethyltryptamine | ChEBI | Bufotenine | ChEBI | DM5-HT | ChEBI | N,N-Dimethylserotonin | ChEBI | 3-[b-(Dimethylamino)ethyl]-5-hydroxyindole | Generator | 3-[Β-(dimethylamino)ethyl]-5-hydroxyindole | Generator | 1H-indol-5-Ol, {3-[2-(dimethylamino)ethyl]-} | HMDB | 3-(2-(Dimethylamino)ethyl)-1H-indol-5-ol (acd/name 4.0) | HMDB | 3-(2-Dimethylaminoethyl)-5-indolol | HMDB | 3-(2-Dimethylaminoethyl)indol-5-ol | HMDB | 3-(beta-Dimethylaminoethyl)-5-hydroxyindole | HMDB | 3-[2-(Dimethylamino)ethyl]-1H-indol-5-ol | HMDB | 3-[2-(Dimethylamino)ethyl]-indol-5-ol | HMDB | 5-Hydroxy-N, N-dimethyltryptamine | HMDB | Cinobufotenine | HMDB | Cohoba | HMDB | Dimethylserotonin | HMDB | indol-5-Ol, {3-[2-(dimethylamino)ethyl]-} | HMDB | Mapine | HMDB | Mappin | HMDB | Mappine | HMDB | N, N-Dimethylserotonin | HMDB | N,N-Dimethyl-5-hydroxytryptamine | HMDB | {3-[(2-dimethylamino)ethyl]-5-indolol} | HMDB | {3-[(beta-dimethylamino)ethyl]-5-hydroxyindole} | HMDB | N,N Dimethyl 5 hydroxytryptamine | HMDB | 5 Hydroxy N,N dimethyltryptamine | HMDB | Bufotenin | KEGG |
|
---|
Chemical Formula | C12H16N2O |
---|
Average Molecular Weight | 204.2682 |
---|
Monoisotopic Molecular Weight | 204.126263144 |
---|
IUPAC Name | 3-[2-(dimethylamino)ethyl]-1H-indol-5-ol |
---|
Traditional Name | bufotenine |
---|
CAS Registry Number | 487-93-4 |
---|
SMILES | CN(C)CCC1=CNC2=C1C=C(O)C=C2 |
---|
InChI Identifier | InChI=1S/C12H16N2O/c1-14(2)6-5-9-8-13-12-4-3-10(15)7-11(9)12/h3-4,7-8,13,15H,5-6H2,1-2H3 |
---|
InChI Key | VTTONGPRPXSUTJ-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as serotonins. Serotonins are compounds containing a serotonin moiety, which consists of an indole that bears an aminoethyl a position 2 and a hydroxyl group at position 5. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Indoles and derivatives |
---|
Sub Class | Tryptamines and derivatives |
---|
Direct Parent | Serotonins |
---|
Alternative Parents | |
---|
Substituents | - Serotonin
- Hydroxyindole
- 3-alkylindole
- Indole
- Alkaloid or derivatives
- 1-hydroxy-2-unsubstituted benzenoid
- Aralkylamine
- Substituted pyrrole
- Benzenoid
- Pyrrole
- Heteroaromatic compound
- Tertiary aliphatic amine
- Tertiary amine
- Azacycle
- Hydrocarbon derivative
- Organopnictogen compound
- Organic oxygen compound
- Amine
- Organooxygen compound
- Organonitrogen compound
- Organic nitrogen compound
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 146.5 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Bufotenin,1TMS,isomer #1 | CN(C)CCC1=C[NH]C2=CC=C(O[Si](C)(C)C)C=C12 | 2020.9 | Semi standard non polar | 33892256 | Bufotenin,1TMS,isomer #2 | CN(C)CCC1=CN([Si](C)(C)C)C2=CC=C(O)C=C12 | 2090.1 | Semi standard non polar | 33892256 | Bufotenin,2TMS,isomer #1 | CN(C)CCC1=CN([Si](C)(C)C)C2=CC=C(O[Si](C)(C)C)C=C12 | 2070.4 | Semi standard non polar | 33892256 | Bufotenin,2TMS,isomer #1 | CN(C)CCC1=CN([Si](C)(C)C)C2=CC=C(O[Si](C)(C)C)C=C12 | 2130.4 | Standard non polar | 33892256 | Bufotenin,1TBDMS,isomer #1 | CN(C)CCC1=C[NH]C2=CC=C(O[Si](C)(C)C(C)(C)C)C=C12 | 2258.4 | Semi standard non polar | 33892256 | Bufotenin,1TBDMS,isomer #2 | CN(C)CCC1=CN([Si](C)(C)C(C)(C)C)C2=CC=C(O)C=C12 | 2311.8 | Semi standard non polar | 33892256 | Bufotenin,2TBDMS,isomer #1 | CN(C)CCC1=CN([Si](C)(C)C(C)(C)C)C2=CC=C(O[Si](C)(C)C(C)(C)C)C=C12 | 2514.5 | Semi standard non polar | 33892256 | Bufotenin,2TBDMS,isomer #1 | CN(C)CCC1=CN([Si](C)(C)C(C)(C)C)C2=CC=C(O[Si](C)(C)C(C)(C)C)C=C12 | 2570.1 | Standard non polar | 33892256 |
|
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Bufotenin GC-MS (Non-derivatized) - 70eV, Positive | splash10-0a4i-9200000000-0af816b35b1e16d258a1 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Bufotenin GC-MS (1 TMS) - 70eV, Positive | splash10-0a4i-9130000000-7bbf336895ab1b156223 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Bufotenin GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Bufotenin GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | MS | Mass Spectrum (Electron Ionization) | splash10-0a4i-9100000000-3e8c21621c306ca36dec | 2014-09-20 | Not Available | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Bufotenin 10V, Positive-QTOF | splash10-0a4i-0390000000-af3dd65f76ad8654b621 | 2016-08-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Bufotenin 20V, Positive-QTOF | splash10-08fr-0940000000-8952400d2cb6d011de82 | 2016-08-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Bufotenin 40V, Positive-QTOF | splash10-01qa-1900000000-34b8e0879f296431d1e8 | 2016-08-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Bufotenin 10V, Negative-QTOF | splash10-0udi-0090000000-59bc27deb381d771d0ae | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Bufotenin 20V, Negative-QTOF | splash10-0udi-1290000000-c4aa46abeccd608387a9 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Bufotenin 40V, Negative-QTOF | splash10-0536-5900000000-1b322d788e0c55bfa242 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Bufotenin 10V, Negative-QTOF | splash10-0udi-0190000000-aa5796e407ec72620b1b | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Bufotenin 20V, Negative-QTOF | splash10-0ue9-0970000000-fa89d4528ce714421e8a | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Bufotenin 40V, Negative-QTOF | splash10-001i-1900000000-df031839bb432c50ef0d | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Bufotenin 10V, Positive-QTOF | splash10-0a4i-0190000000-7230690add489b3c18b9 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Bufotenin 20V, Positive-QTOF | splash10-0bt9-1950000000-42c05e07b418d453a0a8 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Bufotenin 40V, Positive-QTOF | splash10-0a4i-8900000000-cd0c40dcec1955a75dcb | 2021-09-22 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum |
IR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M-H]-) | 2023-02-04 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+H]+) | 2023-02-04 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+Na]+) | 2023-02-04 | FELIX lab | View Spectrum |
|
---|
Biological Properties |
---|
Cellular Locations | Not Available |
---|
Biospecimen Locations | |
---|
Tissue Locations | Not Available |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details |
|
---|
Abnormal Concentrations |
---|
| |
Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal cancer | | details |
|
---|
Associated Disorders and Diseases |
---|
Disease References | Colorectal cancer |
---|
- Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18. [PubMed:25037050 ]
|
|
---|
Associated OMIM IDs | |
---|
External Links |
---|
DrugBank ID | DB01445 |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | FDB111673 |
---|
KNApSAcK ID | C00001402 |
---|
Chemspider ID | 9839 |
---|
KEGG Compound ID | C08299 |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Bufotenin |
---|
METLIN ID | Not Available |
---|
PubChem Compound | 10257 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 3210 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | M01408 |
---|
MarkerDB ID | Not Available |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | - Takeda N, Ikeda R, Ohba K, Kondo M: Bufotenine reconsidered as a diagnostic indicator of psychiatric disorders. Neuroreport. 1995 Nov 27;6(17):2378-80. [PubMed:8747157 ]
- Carpenter WT Jr, Fink EB, Narasimhachari N, Himwich HE: A test of the transmethylation hypothesis in acute schizophrenic patients. Am J Psychiatry. 1975 Oct;132(10):1067-71. [PubMed:1058643 ]
- Ciprian-Ollivier J, Cetkovich-Bakmas MG: Altered consciousness states and endogenous psychoses: a common molecular pathway? Schizophr Res. 1997 Dec 19;28(2-3):257-65. [PubMed:9468359 ]
- Pomilio AB, Vitale AA, Ciprian-Ollivier J, Cetkovich-Bakmas M, Gomez R, Vazquez G: Ayahoasca: an experimental psychosis that mirrors the transmethylation hypothesis of schizophrenia. J Ethnopharmacol. 1999 Apr;65(1):29-51. [PubMed:10350367 ]
- Sponheim E, Myhre AM, Reichelt KL, Aalen OO: [Urine peptide patterns in children with milder types of autism]. Tidsskr Nor Laegeforen. 2006 May 25;126(11):1475-7. [PubMed:16732341 ]
|
---|